EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The plasma EBV DNA load with IL-6 and VEGF levels as predictive and prognostic biomarker in nasopharyngeal carcinoma

Sampa Ghose, Swarnaditya Roy, Vivek Ghosh, Surender K Sharawat, Raja Pramanik, Subhrajit Biswas, Ahitagni Biswas

Virology Journal · 2024

DOI: 10.1186/s12985-024-02473-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Virology Journal, 2024. Verfasst von Sampa Ghose und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, 110029, India. sampaghose@gmail.com. Hauptthemen laut MEDLINE: Interleukin-6, Nasopharyngeal Neoplasms, Viral Load, Herpesvirus 4, Human. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nasopharyngeal carcinoma (NPC) is often diagnosed at a very advanced stage due to its location and non-specific initial symptoms. Moreover, no clinically useful serological marker has been established so far for early detection of NPC. In this study, we have investigated the clinical significance of plasma Epstein-Barr virus DNA load along with interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) levels to evaluate if these three all together can be useful as a strong serological marker for early detection and prediction of treatment response in patients with NPC. Plasma EBV DNA load, IL-6 level, VEGF expressions were measured in 24 patients with NPC at presentation and various time points during and after treatment. There was a positive correlation between high plasma EBV DNA load with higher IL-6 and VEGF expression, which was closely associated with therapeutic response as well. Persistent or recurrent plasma EBV load with higher IL-6 and VEGF levels can potentially predict disease progression and may be useful to select patients for additional therapy and longer follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-6Nasopharyngeal NeoplasmsViral LoadHerpesvirus 4, HumanDNA, ViralVascular Endothelial Growth Factor ANasopharyngeal CarcinomaCarcinomaEpstein-Barr Virus InfectionsHumansFemaleMaleMiddle AgedAdultPrognosisBiomarkersAgedPlasma

Stichwörter der Autor:innen

BiomarkersEpstein Barr virus (EBV)Interleukin-6 (IL-6)Nasopharyngeal carcinoma (NPC)Vascular endothelial growth factor (VEGF)

Substanzen

Interleukin-6DNA, ViralVascular Endothelial Growth Factor ABiomarkersVEGFA protein, humanIL6 protein, human

Autor:innen und Institutionen

  • Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, 110029, India. sampaghose@gmail.com.
  • Department of Radiotherapy and Oncology, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, 110029, India.
  • Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida, UP, India.

Zitieren

APA

Ghose, S., Roy, S., Ghosh, V., Sharawat, S. K., Pramanik, R., Biswas, S., & Biswas, A. (2024). The plasma EBV DNA load with IL-6 and VEGF levels as predictive and prognostic biomarker in nasopharyngeal carcinoma. Virology Journal. https://doi.org/10.1186/s12985-024-02473-0

Vancouver

Ghose S, Roy S, Ghosh V, Sharawat SK, Pramanik R, Biswas S, et al. The plasma EBV DNA load with IL-6 and VEGF levels as predictive and prognostic biomarker in nasopharyngeal carcinoma. Virology Journal. 2024. doi:10.1186/s12985-024-02473-0

BibTeX
@article{Ghose2024,
  author = {Ghose, Sampa and Roy, Swarnaditya and Ghosh, Vivek and Sharawat, Surender K and Pramanik, Raja and Biswas, Subhrajit and Biswas, Ahitagni},
  title = {The plasma EBV DNA load with IL-6 and VEGF levels as predictive and prognostic biomarker in nasopharyngeal carcinoma},
  journal = {Virology Journal},
  year = {2024},
  doi = {10.1186/s12985-024-02473-0}
}
Kostenlos starten →